Hypophosphatemic Rickets clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not currently recruiting here
The objectives of this observational study are to characterize XLH disease presentation and progression and to assess long-term effectiveness and safety of burosumab.
San Francisco, California and other locations
Our lead scientists for Hypophosphatemic Rickets research studies include Anthony Portale.